Ultrasound-Based Renal Sympathetic Denervation as Adjunctive Upstream Therapy During Atrial Fibrillation Ablation

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 160 participants.

Also called NCT04182620

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 160 participants (enrolled count) (from the registry)
Sponsor
  • Vivek Reddy Registry lists this organization as the lead sponsor
Registry
  • NCT NCT04182620
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04182620. Randomized; double masking; primary purpose treatment. Start 2020-07-08 (actual); primary completion 2025-02-26 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Ultrasound-Based Renal Sympathetic Denervation as Adjunctive Upstream Therapy During Atrial Fibrillation Ablation
Acronym
ULTRA-HFIB
Intervention (Device)
renal denervation
Intervention (Device)
Catheter ablation
Lead sponsor
Vivek Reddy (class: other)

Record details

Record id
cardio:ct-nct04182620
Content hash
912fc1717f27a28a3e1ac185bcf5ac896cf04fc73a3f6b2c9c1c75354f62b6d2